TDC
PMC

Thompson Davis & Co’s PharMerica Corporation PMC Stock Holding History

Thompson Davis & Co’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-125
Closed -$4K – 1242
2015
Q4 		$4K Hold
125
– – 0.01% 911
2015
Q3 		$4K Buy
+125
New +$4.2K 0.01% 909

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thompson Davis & Co's PMC Position: Q1 2016 in Review

Thompson Davis & Co sold out of PharMerica Corporation (PMC) in Q1 2016, closing a stake of 125 shares — an estimated $4K sold.

Thompson Davis & Co first reported a position in PMC in Q3 2015 and held it in 2 quarters. The position peaked at $4K in Q4 2015. 169 funds tracked by Wall St. Rank hold PMC as of Q1 2016.

  • Thompson Davis & Co reported no remaining PharMerica Corporation position as of Q1 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 125 PharMerica Corporation shares in Q1 2016, an estimated $4K.
  • Thompson Davis & Co first reported a position in PharMerica Corporation in Q3 2015 and held it in 2 quarters.
  • Thompson Davis & Co's PharMerica Corporation position peaked at $4K in Q4 2015.
  • 169 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2016.

Based on Thompson Davis & Co's 13F filing for Q1 2016, filed 2 May 2016.